Brussels - Delayed Quote EUR

Financière de Tubize SA (TUB.BR)

118.40
-3.60
(-2.95%)
As of 1:12:03 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
2,236.14
2,236.14
2,077.59
1,828.07
1,497.05
Gross Profit
-2,236.14
-2,236.14
-2,077.59
-1,828.07
-1,497.05
Operating Expense
-10.38
-10.38
-351.67
-5.29
36.52
Operating Income
-2,225.76
-2,225.76
-1,725.92
-1,822.78
-1,533.57
Net Non Operating Interest Income Expense
-3,529.02
-3,529.02
-3,342.66
-2,039.17
85,080.19
Pretax Income
90,104.33
90,104.33
88,151.27
85,169.89
83,602.31
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
90,104.33
90,104.33
88,151.27
85,169.89
83,602.31
Diluted NI Available to Com Stockholders
90,104.33
90,104.33
88,151.27
85,169.89
83,602.31
Basic EPS
2.02
2.02
1.98
1.91
1.88
Diluted EPS
2.02
2.02
1.98
1.91
1.88
Basic Average Shares
44,512.60
44,512.60
44,512.60
44,512.60
44,512.60
Diluted Average Shares
44,512.60
44,512.60
44,512.60
44,512.60
44,512.60
Total Operating Income as Reported
-2,235.98
-2,235.98
-2,143.97
--
--
Total Expenses
2,225.76
2,225.76
1,725.92
1,822.78
1,533.57
Net Income from Continuing & Discontinued Operation
90,104.33
90,104.33
88,151.27
85,169.89
83,602.31
Normalized Income
90,104.33
90,104.33
88,151.27
-3,863.24
83,582.49
Interest Income
24.66
24.66
10.75
0
86,457.77
Interest Expense
2,497
2,497
2,336
1,718.79
1,315.38
Net Interest Income
-3,529.02
-3,529.02
-3,342.66
-2,039.17
85,080.19
EBIT
92,601.33
92,601.33
90,487.27
86,888.68
84,917.69
EBITDA
92,601.79
92,601.79
90,487.27
86,888.68
84,917.69
Reconciled Cost of Revenue
2,236.14
2,236.14
2,077.59
1,828.07
1,497.05
Reconciled Depreciation
0.46
0.46
0
0
0
Net Income from Continuing Operation Net Minority Interest
90,104.33
90,104.33
88,151.27
85,169.89
83,602.31
Total Unusual Items Excluding Goodwill
0
0
0
89,033.13
19.82
Total Unusual Items
0
0
0
89,033.13
19.82
Normalized EBITDA
92,601.79
92,601.79
90,487.27
-2,144.45
84,897.87
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

UCB.BR UCB SA
149.90
-2.88%
 
ARGX.BR argenx SE
474.20
-4.40%
 
25I.SG ImmuPharma PLC
0.0285
-3.39%
 
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
 
XUPB.F Genfit S.A.
3.7200
-1.59%
 
688428.SS InnoCare Pharma Limited
19.99
-2.77%
 
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
91.73
-7.80%
 
BSFAF BSF Enterprise Plc
0.0584
0.00%
 
CSJA.F CSL Limited
67.00
+0.75%
 
6XC.F Soleno Therapeutics, Inc.
68.65
+5.86%